https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy: is gastroparesis a factor? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22234 4, respectively), the duration of acid and non-acid reflux in a 24-h period, and the number of reflux episodes lasting longer than 5 min. Results: No statistical difference was seen between the patients with GP and controls with respect to the total number or duration of acid reflux events, total number and duration of non-acid reflux events or the duration of longest reflux episodes. The number of non-acid reflux episodes with a pH > 7 was higher in subjects with GP than in controls. In addition, acid reflux episodes were more prolonged (lasting longer than 5 min) in the GP patients than in controls; however, these values did not reach statistical significance. Thirty-five patients had recorded symptoms during the 24 h study and of the 35 subjects, only 9% (n = 3) had a positive symptom association probability (SAP) for acid/non-acid reflux and 91% had a negative SAP. Conclusion: The evaluation of patients with a documented history of GP did not show an association between GP and more frequent episodes of non-acid reflux based on MII-pH testing.]]> Wed 11 Apr 2018 12:43:08 AEST ]]> The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53012 Tue 07 Nov 2023 08:45:02 AEDT ]]> Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55833 Thu 27 Jun 2024 12:28:32 AEST ]]> Effects of antidepressants on gastric function in patients with functional dyspepsia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36109 post hoc appraisal of the data was performed categorizing patients according to the Rome III subgrouping (PDS and EPS). Results: In total, 292 subjects were randomized; mean age=44 yrs. 21% had delayed gastric emptying. Neither antidepressant altered gastric emptying, even in those with baseline delayed gastric emptying. GA increased with ADTx (P=0.02). Neither antidepressant affected the maximal-tolerated volume (MTV) of the nutrient drink test although aggregate symptom scores improved compared to placebo (P=0.04). Patients with the combined EPS-PDS subtype (48%) had a lower MTV on the nutrient drink test compared to the EPS group at baseline (P=0.02). Postprandial bloating improved with both AMI (P=0.03) and ESC (P=0.02). Conclusions: Amitriptyline (50 mg) improves FD symptoms but does not delay gastric emptying, even in patients with baseline delayed gastric emptying. GA improved with low-dose ADTx; the precise mechanism of action is unknown warranting further study.]]> Thu 06 Feb 2020 14:11:07 AEDT ]]> Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12383 Sat 24 Mar 2018 08:18:00 AEDT ]]>